In vitro Passive and Iontophoretically Assisted Transport of Salbutamol sulphate through Hairless Mice Skin
DOI:
https://doi.org/10.37285/ijpsn.2010.3.1.3Abstract
Investigations were carried out to ascertain the relative importance of the described mechanism in iontophoretic transport using an ionizable drug salbutamol sulphate, which has two pKa values 9.3 (for amino group) and 10.3 (for phenolic group). Ionization of salbutamol sulphate varies with pH, hence the rate and extent of transport across the skin can be enhanced, controlled and manipulated by the application of factors like anodal and cathodal current at varied pH of donor solution and current densities. To determine these parameters, experiments were performed and data was collected at 7.4, 9.3, 10.3 and 11 pH using 4mg/ml drug concentration and 0.3mA/cm2 current density for 6 hours. After establishing the pH for optimum transport of drug, effect of current density (0.1, 0.2, 0.3 and 0.4 mA/cm2) on the transport of drug (keeping drug concentration constant) were investigated. Passive diffusion of salbutamol sulphate was maximal at pH 10.3 and 9.3, when unionized form of drug was 50%. Anodal iontophoresis at pH 7.4 was most effective (significant result, p < 0.05) in transport of drug across skin as compared to cathodal iontophoresis at pH 11. The effect of current density on steady state flux by salbutamol sulphate during anodal iontophoresis at 7.4 pH showed 2.26 and 28.05µg/cm2/h at 0.0 i.e., passive diffusion and 0.4 mA/cm2, respectively. Thus, flux was enhanced nearly 12 times during anodal iontophoresis.
Downloads
Metrics
Keywords:
Iontophoresis, transport, steady state flux, current density, salbutamol sulphate
Downloads
Published
How to Cite
Issue
Section
References
Artusi M, Nicoli S, Colombo P, Bettini R, Sacchi A, and Sanli P. Effect of chemical enhancers and iontophoresis on thiocolchicoside permeation across rabbit and human skin in vitro. J Pharm Sci. 2004; 93: 2431-2438.
Banga AK, Bose S, Ghosh TK. Iontophoresis and electroporation: comparisons and contrasts. Int J Pharm. 1999; 179: 1-19.
Bayon Rodriguez AM, Corish J, Corrigan OI. In vitro passive and iontophoretically assisted transport of salbutamol sulphate across synthetic membranes. Drug Dev Ind Pharm. 1993; 19:1169-1181.
Bose S, Ravis WR, Lin YJ, Zhang L, Hofmann GA, Banga AK. Electrically-assisted transdermal delivery of buprenorphine. J Cont Rel. 2001; 73: 197-203.
Bumette RR, Marrero D. Comparison between the iontophoretic and passive transport of thyrotropin releasing hormone across excised nude mouse skin. J Pharm Sci. 1986; 75: 738-743.
Burnette RR, Orgipattanakal B. Characterization of pore transport properties and tissue alteration of excised human skin during iontophores. J Pharm Sci.1988; 77: 132-137.
Care V. CPCSEA Guidelines for laboratory animal facility. Indn J Pharmacol. 2003; 35: 257-274.
Charro MB, In vitro optimization of dexamethasone phosphate delivery by iontophoresis. Phys Ther. 2008; 88: 1177–1185.
Davis KA, Anseth KS. Controlled release from cross linked degradable networks, Crit Rev Ther Drug Carr Syst. 2002; 19: 385-423.
De Graaff AM, Li GL, van Aelst AC, Bouwstra JA. Combined chemical and electrical enhancement modulates stratum corneum structure. J Cont Rel. 2003; 90: 49-58.
Delgado-Charro MB, Guy RH. Transdermal iontophoresis for controlled drug delivery and non-invasive monitoring. STP Pharma Sci. 2001; 11: 403-414.
DelTerzo S, Behl CR, Nash RA. Iontophoretic transport of a homologous series of ionized and nonionized model compounds: influence of hydrophobicity and mechanistic interpretation. Pharm Res.1989; 6:85-90.
Droog EJ, Sjoberg F. Non specific vasodilation during transdermal iontophoresis. Microvascular Res. 2003; 65: 172-178.
Faruk A, Singh G, Ishar MPS. Effect of drug concentration and permeation enhancer on iontophoretic transport of salbutamol sulphate in vitro. Int J Pharm Sci and Nanotech. 2009; 1: 341-348.
Hamann H, Hodges M, Evans B. Effectiveness of iontophoresis of anti-inflammatory medications in the treatment of common musculoskeletal inflammatory conditions: a systematic review. Phys Ther Rev. 2006; 11: 190-194.
Hayton WL, Chen T. Correction of perfusate concentration samples removal. J Pharm Sci. 1982; 71: 820-821.
Huang, YY, Wu SM, Wang CY, Jiang TS. A strategy to optimize the operation conditions in iontophoretic transdermal delivery of pilocarpine. Drug Dev Ind Pharm. 1995; 21:1631-48.
Ijzerman AP, Bultsma T, Timmerman H, Zaagsma J. The ionization of β-adrenoceptor agonists: a method for unravelling ionization schemes. J Pharm Pharmacol. 1984; 36: 11–15.
Julraht K, Keith AP, James AW. Development of a transdermal delivery device for melatoin in vitro studies. Drug Dev Ind Pharm. 1995; 21: 1377-1387.
Kalia YN, Naik A, Garrison J, Guy RH. Iontophoretic drug delivery. Adv Drug Deliv Rev. 2004; 56: 619-58.
Kamath SS, Gangarosa LP. Electrophoretic evaluation of the mobility of drugs suitable for iontophoresis. Exp Clin Pharmacol. 1995; 17: 227-232.
Kochhar C, Imanidis G. In vitro transdermal iontophoretic delivery of leuprolide under constant current application. J Cont Rel. 2004; 98: 25-35.
Leboulanger B, Guy RH, Delgado-Charro MB. Non-invasive monitoring of phenytoin by reverse iontophoresis. Eur J Pharm Sci. 2004; 22: 427-33.
Lelawongs P, Liu JC, Chien YW. Transdermal iontophoretic delivery of arginine-vasopressin (II): Evaluation of electrical and operational factors. Int J Pharm. 1990; 61: 179-188.
Malkki L, Tammilehto S. Decomposition of salbutamol in aqueous solutions. I. The effect of pH, temperature and drug concentration. Int J Pharm, 1990; 63: 17-22.
Malkki L, Purra K, Kahkonen K, Tarnmilehto S. Decomposition of salbutamol in aqueous solutions. II. The effect of buffer species, pH, buffer concentration and antioxidants. Int J Pharm. 1995; 117: 189-195.
Marro D, Kalia YN, Delgado-Charro MB, Guy RH. Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharm Res. 2001; 18: 1701-1708.
Martin A, Swarbrick J, Canmarata A. Physical Pharmacy, 3rd. Lea & Febiger , Philadelphia; 1983. p-222, 421.
Miller LL, Kolaskie CJ, Smith GA, Rivier J. Transdermal iontophoresis of gonadotropin releasing hormone and two analogues. J Pharm Sci. 1990; 79: 490-493.
Morimoto K, Iwakura Y, Nakatani E, Miyazaki M, Tojima H. Effects of proteolytic enzyme inhibitors as absorption enhancers on the transdermal iontophoretic delivery of calcitonin in rats. J Pharm Pharmacol. 1992; 44:216-218.
Mudry B, Carrupt PA, Guy RH, Delgado-Charro MB. Quantitative structure-permeation relationship for iontophoretic transport across the skin. J Cont Rel. 2007; 122: 165-172.
Mudry B, Guy RH, Delgado-Charro MB. Prediction of iontophoretic transport across the skin. J Cont Rel. 2006; 111: 362–367.
Nair VB, Panchagnula R. Effect of iontophoresis and fatty acids on permeation of Arginine Vasopression through rat skin. Pharmacol Res. 2003; 47: 565-569.
Pikal MJ, Shah S. Transport mechanisms in iontophoresis II. Electroosmotic flow and transference number measurements for hairless mouse skin. Pharm Res. 1990; 7: 213-21.
Pikal MJ. The role of electroosmotic flow in transdermal iontophoresis. Adv Drug Deliv Rev. 2001: 46; 281-305.
Pillai O, Nair V, Panchagnula R. Transdermal iontophoresis of insulin: IV. Influence of chemical enhancers. Int J Pharm 2004; 269:109-20.
Roberts MS, Lai PM, Cross SE Yoshida NH. Solute structure as a determinant of iontophoresic transport. In: Potts RO, Guy RH, eds. Mechanisms of Transdermal Drug Delivery. New York: Marcel Dekker Inc; 1997. p.291-349.
Roberts MS, Singh J, Yoshida NH, Currie KI. in “Prediction of Percutaneous Absorption”, , Scott, R. C.; Guy R. H.; Hadgraft, J. (Eds.), IBC Technical Services, London, 1989;pp 231-241.
Santi P, Guy RH. Reverse iontophoresis: parameters determining electroosmotic flow, I: pH and ionic strength. J Cont Rel. 1996; 38:159-165.
Siddiqui O, Roberts MS, Polack AE. The effect of iontophoresis and vehicle pH on the in-vitro permeation of lignocaine through human stratum corneum. J Pharm Pharmacol. 1985; 37:732-735.
Siddiqui O, Roberts MS, Polack AE. Topical absorption of methotrexate: Role of dermal transport. Int J Pharm. 1985a; 27: 193-203.
Siddiqui O, Sun Y, Liu JC, Chien YW. Facilitated transdermal transport of insulin. J Pharm Sci. 1987; 76: 341-345.
Sims SM, Higuchi WI. Base line studies on iontophoretic transport in hairless mouse skin: the effect applied voltage drop and pH on the iontophoresis of a model weak electrolyte. J Memb Sci. 1990; 49: 305-320.
Srinivasan, Higuchi WI. A. model for iontophoretic incorporating the effect of convective solvent flow. Int J Pharm. 1990: 60; 133-138.
Swarbrick J, Lee G, Brom J, Gensmantel WP. Drug permeation through human skin II. Permeability of ionizable compounds. J Pharm Sci. 1984; 73: 1352-1355.
Takahashi Y, Iwata M, Mahila Y. Enhancing effect of switching iontophoresis on transdermal absorption of glibenclamide.Yakugaku Zasshi, 2001; 121: 161-166.
Tuncer DI, John PW, Hadgraft J. Effect of ion complexants on the iontophoresis of salbutamol. Int J Pharm. 1998; 167: 229–231.
Wang Y, Thakur R, Fan Q, Michniak B. Transdermal iontophoresis: combination strategies to improve transdermal iontophoretic drug delivery. Eur J Pharm Biopharm. 2005; 60: 179-91.
Wearly LL, Chein YW. Iontophoretic trandermal permeation of verapamil(III) : effect of binding and concentration gradient on reversibility of skin permeation rate. Int. J. Pharm. 1990; 59: 87-94.
Williams AC, Barry BW. Terpenes and the lipid-protein partitioning theory of skin penetration enhancement. Pharm Res. 1994; 8: 17-24.
